Compare IBRX & SBSW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IBRX | SBSW |
|---|---|---|
| Founded | 2014 | 2013 |
| Country | United States | South Africa |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.2B | 7.6B |
| IPO Year | 2015 | 2019 |
| Metric | IBRX | SBSW |
|---|---|---|
| Price | $8.40 | $9.78 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 5 |
| Target Price | ★ $14.25 | $13.42 |
| AVG Volume (30 Days) | ★ 13.2M | 4.4M |
| Earning Date | 11-03-2026 | 09-01-2026 |
| Dividend Yield | N/A | ★ 6.58% |
| EPS Growth | ★ 38.71 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $113,288,000.00 | N/A |
| Revenue This Year | $99.98 | $28.71 |
| Revenue Next Year | $108.29 | $11.07 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 668.31 | N/A |
| 52 Week Low | $1.95 | $7.87 |
| 52 Week High | $12.43 | $21.29 |
| Indicator | IBRX | SBSW |
|---|---|---|
| Relative Strength Index (RSI) | 42.89 | 41.33 |
| Support Level | $7.71 | $9.16 |
| Resistance Level | $8.51 | $11.08 |
| Average True Range (ATR) | 0.76 | 0.31 |
| MACD | -0.20 | 0.03 |
| Stochastic Oscillator | 9.68 | 45.59 |
ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach harnesses both the adaptive and innate immune systems with the Cancer BioShield platform. The platform is built around the proprietary IL-15 superagonist ANKTIVA (nogapendekin alfa inbakicept) and is supported by a portfolio that includes adenovirus-vectored vaccines, NK-cell therapies, and additional immunomodulators. The company operates in the United States and Europe, with the majority of its revenue coming from the United States.
Sibanye Stillwater Ltd is a South African mining and metals processing group with a diverse portfolio of operations, projects, and investments across five continents. The Group is also one of the foremost recyclers of PGM autocatalysts and has interests in mine tailings retreatment operations. It is a producer of platinum, palladium, and rhodium and is a top-tier gold producer. It also produces and refines iridium and ruthenium, nickel, chrome, copper, and cobalt. Its products are Gold, Nickel, Zinc, Chrome, PGMs, and other. Group operations are divided into two segments, South African Operations and International and recycling operations.